Source: Annual Congress 2009 - Pulmonary Arterial Hypertension Research Award (supported by Actelion Pharmaceuticals)
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vonk Noordegraaf (Amsterdam, Netherlands). Pulmonary Arterial Hypertension Research Award. Annual Congress 2009 - Pulmonary Arterial Hypertension Research Award (supported by Actelion Pharmaceuticals)

Member's Comments

No comment yet.

Related content which might interest you: Ceremony for the ERS Pulmonary Arterial Hypertension Lifetime Achievement Research Award Source: International Congress 2017 – Open questions in pulmonary vascular diseases Year: 2017 Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension Source: Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension Year: 2013 Ceremony for ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension Source: International Congress 2016 – Pulmonary arterial hypertension: future therapeutic approaches Year: 2016 Choir in the Pulmonary Rehabilitation Program Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award Source: International Congress 2015 – IPF: an airway-derived disease? Year: 2015 Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009